Changes in Holdings of Kdi Capital Partners LLC: Q2 2021 vs. Q3 2021

The Kdi Capital Partners LLC is a hedge fund that manages over $604.4 million in assets. The fund recently reported its Q3 2021 13F holdings, and we compared them with the Q2 2021 holdings to see the changes in the fund's investments. In this blog post, we will provide an overview of the Kdi Capital Partners LLC fund, highlight the significant changes in the fund's holdings, and discuss the reasons behind these moves.

Overview of Kdi Capital Partners LLC

Kdi Capital Partners LLC is a New York-based hedge fund that primarily invests in technology, healthcare, and financial sector stocks. The fund's portfolio manager, Dae Koh, has experience in the investment management industry, having previously worked at Goldman Sachs and Maverick Capital. Kdi Capital Partners LLC's investment strategy involves looking for companies with strong fundamentals and reasonable valuations, conducting extensive research and analysis to identify potential investments, and maintaining an active management approach to maximize returns.

Significant changes in Kdi Capital Partners LLC's holdings

One of the most significant changes in Kdi Capital Partners LLC's holdings is the addition of 98,471 shares of the SPDR Ser Tr S&P Biotech (XBI) ETF, valued at $12.379 million. The fund did not hold any shares of XBI in Q2 2021, and this move indicates the fund's bullish outlook on the Biotech sector.

On the other hand, the fund sold almost all its shares of Dollar General Corp (DG), reducing its holdings from 50,328 shares worth $10.89 million in Q2 2021 to just 3,500 shares worth $742,000 in Q3 2021. Similarly, the fund sold most of its shares of Becton Dickinson & Co (BDX), holding only 3,000 shares worth just $737,000, down from 24,135 shares worth $5.869 million in Q2 2021.

Another notable change in holdings is the significant reduction in the fund's investment in Apple Inc (AAPL). Kdi Capital Partners LLC sold 2,192 shares of Apple Inc, valued at $293,000, and now holds only 1,464 shares worth $207,000, down from 3,656 shares worth $501,000 in Q2 2021.

Reasons behind these moves

Kdi Capital Partners LLC's addition of SPDR Ser Tr S&P Biotech (XBI) shares suggests that the fund believes that the Biotech sector will outperform in the future. This move is probably due to the recent developments in the Biotech sector, such as the expected approval of new drugs and treatments, and the increasing demand for COVID-19 vaccines and treatments.

The fund's decision to sell most of its shares of Dollar General Corp (DG) and Becton Dickinson & Co (BDX) can be attributed to the companies' performance, which may not meet the fund's expectations. Additionally, the fund's move to reduce its investment in Apple Inc (AAPL) is probably due to the current uncertainty surrounding the company's future growth prospects.

Conclusion

In conclusion, Kdi Capital Partners LLC is a hedge fund that primarily invests in technology, healthcare, and financial sector stocks. The fund recently reported its Q3 2021 13F holdings, and we compared them with the Q2 2021 holdings to see the changes in the fund's investments. The fund's addition of SPDR Ser Tr S&P Biotech (XBI) shares suggests a bullish outlook on the Biotech sector, while the decision to sell most of its shares of Dollar General Corp (DG), Becton Dickinson & Co (BDX), and Apple Inc (AAPL) is probably due to the companies' performance and prospects. As with any investment, it is crucial to conduct your due diligence before making any investment decisions.